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Abstract
Background: From the first case reports of pandemic influenza (H1N1) 2009 it was clear that a significant proportion of
infected individuals suffered a primary viral pneumonia. The objective of this study was twofold; to assess the utility of the
CURB-65 community acquired pneumonia (CAP) severity index in predicting pneumonia severity and ICU admission, and to
assess the relative sensitivity of nasopharyngeal versus lower respiratory tract sampling for the detection of pandemic
influenza (H1N1) CAP.
Methods: A retrospective cohort study of 70 patients hospitalised for pandemic influenza (H1N1) 2009 in an adult tertiary
referral hospital. Characteristics evaluated included age, pregnancy status, sex, respiratory signs and symptoms, smoking
and alcohol history, CURB-65 score, co-morbidities, disabling sequelae, length of stay and in-hospital mortality outcomes.
Laboratory features evaluated included lymphocyte count, C-reactive protein (CRP), nasopharyngeal and lower respiratory
tract pandemic influenza (H1N1) 2009 PCR results.
Results: Patients with pandemic (H1N1) 2009 influenza CAP differed significantly from those without pneumonia regarding
length of stay, need for ICU admission, CRP and the likelihood of disabling sequelae. The CURB-65 score did not predict CAP
severity or the need for ICU admission (only 2/11 patients admitted to ICU had CURB-65 scores of 2 or 3). Nasopharyngeal
specimens for PCR were only 62.9% sensitive in CAP patients compared to 97.8% sensitivity for lower respiratory tract
specimens.
Conclusions: The CURB-65 score does not predict severe pandemic influenza (H1N1) 2009 CAP or need for ICU admission.
Lower respiratory tract specimens should be collected when pandemic (H1N1) 2009 influenza CAP is suspected.
Citation: Mulrennan S, Tempone SS, Ling ITW, Williams SH, Gan G-C, et al. (2010) Pandemic Influenza (H1N1) 2009 Pneumonia: CURB-65 Score for Predicting
Severity and Nasopharyngeal Sampling for Diagnosis Are Unreliable. PLoS ONE 5(9): e12849. doi:10.1371/journal.pone.0012849
Editor: Keertan Dheda, University of Cape Town, South Africa
Received April 13, 2010; Accepted August 18, 2010; Published September 21, 2010
Copyright:  2010 Mulrennan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Siobhain.Mulrennan@health.wa.gov.au
Introduction
April 2009 heralded the advent of the first influenza pandemic
for 41 years. Cases of the novel pandemic influenza (H1N1) 2009
were identified in Mexico and Southern California and reports of
the clinical outcomes of hospitalised patients soon followed [1],
[2]. Data from Mexico [1] demonstrated that pandemic (H1N1)
2009 could cause severe respiratory illness in previously healthy
young to middle aged people and pregnant females, as well as
those with underlying medical conditions. Pandemic influenza
(H1N1) 2009 pneumonia was characterised by fever cough,
dyspnoea or respiratory distress and patchy alveolar infiltrates.
Since then reports of the clinical features have described either
mild to moderate pneumonia [3] or severe pneumonia [4], [5].
Diagnosis of pandemic influenza (H1N1) 2009 infection in these
studies was confirmed with reverse transcriptase PCR (RT-PCR)
testing, mostly on nasopharyngeal samples, and did not assess the
relative sensitivity between upper and lower respiratory tract
sampling. Moreover, the utility of community acquired pneumo-
nia (CAP) severity indices for pandemic influenza (H1N1) 2009
pneumonia, such as the CURB-65 score, have not been assessed.
When pandemic influenza (H1N1) 2009 first appeared in
Australia in May 2009, it quickly became the dominant circulating
influenza strain through the Australian winter and as of October
16, over 37 000 laboratory-confirmed cases had been recorded,
resulting in nearly 5 000 hospitalizations and 186 deaths [6]. We
describe the clinical and laboratory features of patients diagnosed
with pandemic influenza (H1N1) 2009 at Sir Charles Gairdner
Hospital, a 650 bed tertiary referral hospital in Perth, Western
Australia over a one-month period focussing on the characteristics
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clarify the utility of the CURB-65 score in predicting pneumonia
severity and ICU admission and to assess the relative sensitivity of
upper and lower respiratory tract specimens for PCR diagnosis of
pandemic (H1N1) 2009 in the setting of pneumonia.
Methods
We conducted a retrospective review of patients with pandemic
influenza (H1N1) 2009 attending our hospital over a one-month
period during the winter peak of influenza activity between July
6th and August 6th 2009. A suspected pandemic influenza (H1N1)
2009 case was defined as fever, or history of fever, with acute
respiratory symptoms of cough and/or sore throat. All suspected
cases were either isolated or cohorted, and had nose and throat
swabs collected together with sputum or bronchoscopy samples if
these were clinically indicated. Suspected and confirmed cases
were initially treated with oseltamivir 75 mg twice daily and, if
deemed appropriate, antibacterial therapy. Pandemic influenza
(H1N1) 2009 pneumonia (with/without bacterial co-infection and
from hereon referred to as the pneumonia group) was defined as
symptoms and/or signs of lower respiratory tract infection
together with new pulmonary infiltrates on imaging and a positive
real-time RT-PCR (rRT-PCR) on a lower respiratory tract
sample. Two of the 70 patients did not receive chest imaging
and these, along with individuals with chronic lung disease without
new infiltrates, were categorized as non-pneumonia pandemic
influenza (H1N1) 2009.
Clinical information was obtained by chart review. The data
collected included sex, age, pregnancy status, comorbidities,
smoking and alcohol consumption, respiratory signs and symp-
toms, days of symptoms prior to hospitalisation, CURB-65 score at
hospital presentation, need for ICU admission, length of hospital
stay, and subsequent disability and in-hospital death. This study
was considered to be audit activity according to institutional and
National Health and Medical Research Council criteria [7], [8],
and therefore formal ethics committee approval and informed
consent from the patients was not required. Audit approval was
sought and granted.
Laboratory testing
All samples were processed for pandemic influenza (H1N1)
2009 using routine procedures by PathWest Laboratory Medicine
WA, Queen Elizabeth II Medical Centre as previously described
[9], [10]. Upper respiratory tract specimens included nose and
throat swabs collected using either plastic-shafted dacron swabs
placed into viral transport medium (VTM) or dry cotton-tipped
wire swabs that were vortexed in VTM in the laboratory. Lower
respiratory tract specimens included expectorated sputum, sputum
aspirated via an endotracheal tube, and bronchoalveolar lavage
fluid. RNA extraction from nasopharyngeal swabs was performed
as described elsewhere [10]. Viscose samples, including those from
the lower respiratory tract, were extracted using the QIAamp
Viral RNA Mini kit (QIAGEN, Germany) according to manu-
facturer specifications.
Amplification was performed by rRT-PCR directed to specific
targets in the matrix genes of influenza A and B, and the
haemagglutinin genes of H1 (seasonal), H1 (pandemic) and H3 of
influenza A [9], [10]. An internal PCR inhibitor control was
included for all samples. Cycling was performed using RotogeneQ
real-time thermocyclers (QIAGEN, Germany). The rRT-PCR
assays were performed either in single target reactions or duplex
reactions. Assay sensitivity and specificity was comparable between
both methods and is described in detail elsewhere [10]. The
cycling threshold (CT) for the PCR reaction, a measure of the
strength of the PCR signal that is inversely proportional to the
amount of target genetic material present in the specimen, was
recorded for each sample. Pneumonia patients were recommend-
ed to undergo repeat nasopharyngeal and/or sputum sampling for
rRT-PCR every three days during their admission until clinically
improved.
Bacterial co-infection was diagnosed if the patient returned a
positive culture result for pathologic bacteria from a sterile site (eg
blood) and/or lower respiratory tract specimens, or seroconversion
to atypical bacterial pathogens (eg Mycoplasma pneumoniae,
Chlamydophila pneumoniae, Legionella spp). The lymphocyte
count and C-reactive protein (CRP) level were also recorded, as
lymphopoenia and raised CRP has been previously reported with
pandemic influenza (H1N1) 2009 [3].
Statistics
We performed statistical analysis using GraphPad Prism
software, version 5.02 (GraphPad Software, Inc., San Diego
California USA). We report data for continuous variables as
medians and used the Mann-Whitney test. Categorical variables
were analysed using the Fisher’s exact test. Two-tail P values
,0.05 were considered significant.
Results
All patients meeting the case definition for suspected pandemic
influenza (H1N1) 2009 underwent nasopharyngeal swabbing for
rRT-PCR testing together with sputum or bronchoscopy samples
if available, then commenced oseltamivir. The case definition had
a pre-test predictive value for a positive rRT-PCR result of
approximately 50% (data not shown) and 70 admitted patients (35
male) were confirmed as having pandemic influenza (H1N1) 2009
between July 6
th and August 6
th 2009. Greater than 50% of
patients were aged between 18 and 40 years and 83% were aged
between 18 and 60 years. There were eight immunosuppressed
patients; four had received solid organ transplants, two were
receiving cytotoxic chemotherapy, one had Addison’s disease and
one had systemic lupus erythematosus.
The baseline characteristics of 35 patients with pandemic
influenza (H1N1) 2009 pneumonia were compared to the 35 non-
pneumonia cases (Table 1).
Eleven pneumonia patients required ICU admission; ten
required intubation and ventilation, one was observed in ICU
overnight, three required extracorporeal membrane oxygenation
(ECMO) and two died. The significant differences between the
non-pneumonia and pneumonia pandemic influenza (H1N1) 2009
cases were the increased frequency of ICU care, the prolonged
length of hospital stay, more disability following infection and a
higher peak CRP level (reference range ,5 mg/L).
When the CURB-65 score was applied to the pneumonia
patients 31 of the 35 (88%) patients had a CURB-65 score of only
0 or 1. At the time of ICU admission only one of the 11 patients
had a CURB-65 score of 2 and one patient had a score of 3. The
remaining nine (82%) ICU admissions had a score of 0 (n=6) or 1
(n=3). The 2 patients who died had a CURB-65 score of 1 and 3
and 2 patients with a CURB-65 score of 2 did not require ICU
admission.
There was no difference in the rate of bacterial co-infection in
patients with and without pneumonia (5/35 and 4/35 respectively,
p=1.0) indicating the majority of the pneumonia group had a
primary viral pneumonia.
Twenty five pneumonia patients had both nasopharyngeal and
lower respiratory tract samples collected. All but one pneumonia
H1N1 2009 Pneumonia
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Characteristics Value (%) p-Value
All patients Pneumonia Non-pneumonia
M/F 35/35 (50) 20/15 (57) 15/20 (43) 0.3
Median (range) age (years) 38 (18–76) 38 (21–70) 38 (18–76) 1.0
Age Group
18 to 40 38 (54) 19 (54) 19 (54)
40 to 60 22 (31) 12 (34) 10 (29)
60+ 10 (14) 4 (11) 6 (17)
Median (range) days of symptoms
prior to presentation
4 (1–21) 5 (1–14) 3 (1–21) 0.4
Median (range) length of stay (days) 4 (0–74) 6 (1–74) 3 (0–23) 0.002
Symptom or outcome
Cough 63 (90) 31 (89) 32 (91) 1.0
Fever/rigors 34 (49) 16 (46) 18 (51) 0.8
Dyspnoea 31 (44) 19 (54) 12 (34) 0.1
Sputum production 30 (43) 13 (37) 17 (49) 0.5
Myalgia/arthralgia 18 (26) 9 (26) 9 (26) 1.0
Sore throat 17 (24) 5 (14) 12 (34) 0.1
Wheeze 14 (20) 8 (23) 6 (17) 0.8
Coryza 7 (10) 4 (11) 3 (9) 1.0
Headachce 6 (9) 1 (3) 5 (14) 0.1
Admitted to ICU 11 (16) 11 (31) 0 ,0.001
Bacterial co-infection 9 (13) 5 (14) 4 (11) 1.0
Disabling sequelae 9 (13) 9 (26) 0 0.002
Death 2 (3) 2 (6) 0 0.5
Comobidities
Asthma 19 (27) 12 (34) 7 (20) 0.3
Diabetes 12 (17) 6 (17) 6 (17) 1.0
COPD/emphysema 6 (9) 1 (3) 5 (14) 0.1
Cystic fibrosis 5 (7) 2 (6) 3 (9) 1.0
Pregnancy 5 (7) 4 (11) 1 (3) 0.4
Immunosuppressed 8 (8) 3 (9) 5 (14) 0.7
Smoking history
Current smoker 24 (34) 13 (37) 11 (31) 0.8
Ex-smoker 8 (11) 6 (17) 2 (6) 0.3
Non-smoker 26 (37) 11 (31) 15 (43) 0.5
Not recorded 12 (17) 5 (14) 7 (20) 0.8
Alcohol consumption
Yes 18 (26) 7 (20) 11 (31) 0.3
No 19 (27) 10 (29) 9 (26) 1.0
Not recorded 33 (47) 18 (51) 15 (43) 0.6
CURB score
0 24 (69)
1 7 (20)
2 3 (9)
3 1 (3)
Laboratory data
Median (range) lymphocyte nadir
(x10
9/L)
0.73
(0.00–2.54)
0.68
(0.00–2.15)
0.83
(0.30–2.54)
0.1
Median (range) CRP peak (mg/L) 72 (5.6–440) 97 (16–390) 51 (5.6–440) 0.048
doi:10.1371/journal.pone.0012849.t001
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rRT-PCR results (97.8% sensitivity) but only 62.9% of the
nasopharyngeal samples were rRT-PCR positive (fig. 1). Despite
the commencement of oseltamivir for all patients on admission,
the lower respiratory tract specimens remained positive for many
days with only a slow rise in the rRT-PCR CT value (fig. 1).
Several patterns of respiratory tract rRT-PCR positivity were
revealed by following individual pneumonia patients with repeat
upper and lower respiratory tract samples (fig. 2)
Discussion
Pandemic influenza (H1N1) 2009 can be associated with severe
illness and death in previously healthy individuals. The patient
characteristics of our cohort mirror those described elsewhere in
the literature with the majority of adult patients suffering more
severe disease requiring admission aged between 18 and 40
(Table 1). Reported comorbidities included asthma, COPD,
diabetes, immunosuppression and pregnancy [3], [5], [11]. As
expected, those with pneumonia had a worse clinical outcome
with an increase median length of hospital stay, with almost one-
third requiring ICU admission, and more disability following their
influenza. Only two pneumonia deaths were recorded, which may
be a reflection of the intensive supportive care the pneumonia
patients received, or the younger age and lack of pre-existing
comorbidities in this group compared to the patients usually
admitted for CAP following seasonal influenza.
The CURB-65 score, a widely used tool used to enable
stratification of CAP patients into mortality risk groups facilitating
management including the need for ICU assessment (score 4 or 5)
[12], was unhelpful in assessing the severity of influenza pneumonia
in our cohort. Buising et al [13] found this score predicted mortality
well but was only 58% sensitive for predicting ICU admission in
their single centre study. In our centre nearly 90% of those with
pneumonia or those requiring ICU admission had a CURB-65
score of 0 or 1. According to the CURB-65 results, 89% of our
pneumonia cohort and 82% of those admitted to ICU would be
categorised as potentially suitable for management as outpatients.
Our findings therefore extend those of Buising et al [13] that the
CURB-65score,whenappliedtopandemicinfluenza(H1N1)2009,
is not suitable for predicting ICU admission.
Rapid detection of pandemic (H1N1) 2009 infection is
performed using rRT-PCR testing due to the unreliability of
rapid antigen tests [14], [15] and our laboratory used the
technique extensively throughout the pandemic [10]. We have
demonstrated suboptimal sensitivity (62.9%) of nasopharyngeal
sampling in establishing the diagnosis of pandemic influenza
(H1N1) 2009 pneumonia (fig. 1). Several large case series have
relied on RT-PCR testing of nasopharyngeal sampling for
diagnosis [1], [3]. Our findings, and those of others [15], suggest
that lower respiratory tract samples, if available, should be
obtained when investigating for suspected pandemic influenza
(H1N1) 2009 pneumonia. The early experience in Mexico [1]
showed that only 18% of patients admitted with pneumonia or
influenza-like-illness had positive nasopharyngeal swabs for
pandemic influenza A (H1N1) 2009. It is possible that a number
of these ‘swab negative’ patients were indeed false negatives, which
may have been confirmed with lower respiratory tract sampling.
In a cohort of 426 persons with mostly mild pandemic influenza
(H1N1) 2009 infection who underwent regular nasopharyngeal
swabbing, the rRT-PCR was found to remain positive for a
median of 6 days (range, 1–17) [3]. We also sampled our pandemic
influenza (H1N1) 2009 pneumonia patients regularly but from
both the upper and lower respiratory tract and also found that the
nasopharyngeal swabs often became negative after several days.
However, the lower respiratory tract samples remained positive for
many days, often well after the nasopharyngeal swabs had become
negative, with very little reduction in rRT-PCR signal strength as
shown by the slow rise in rRT-PCR CT value (fig. 1,2). Clinicians
should be wary of relying on nasopharyngeal swab results if using
rRT-PCR negativity as an infection control tool for the release of
patients from isolation. There are several possible explanations for
the relative lack of sensitivity of nasopharyngeal swabs; the viral
load in lower respiratory tract secretions may be greater, the
collection of a fluid specimen may preserve the viral RNA better
than a swab, or there may have been poor sampling technique for
Figure 1. Pandemic influenza (H1N1) 2009 rRT-PCR detections for nasopharyngeal and lower respiratory tract samples from 25
pneumonia patients.
doi:10.1371/journal.pone.0012849.g001
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obtained. In support of the latter was the observation that some
patients were symptomatic yet nasopharyngeal swab-negative on
day 1 only to be swab-positive on day 2. Instructions with step-by-
step pictures on how to collect nasopharyngeal swabs were
circulated to all clinical staff at the start of the winter season but it
was impossible to supervise individual collections.
This study has several limitations. Firstly, it was performed in one
adult tertiary hospital suchthat the results may not be generalised to
the pediatric population and other regions of the world. Secondly,
the rate of bacterial co-infection in the pneumonia group may have
been underestimated. Thirdly, the CURB-65 score is the standard
severity index applied to our community acquired pneumonia
patients admitted to our hospital. We did not apply other severity
indices to our pneumonia cohort, which may have been more
accurate than the CURB-65 score. Finally, as we did not perform
viral culture on all specimens due to limited testing capacity, we
could not confirm that patients with ongoing rRT-PCR positivity
were infectious to other patients and staff.
In conclusion, pandemic influenza (H1N1) 2009 pneumonia
was associated with prolonged hospital admission, increased ICU
admission and increased disability compared to non-pneumonia
pandemic influenza (H1N1) 2009 in our hospital. The CURB-65
score did not predict pandemic influenza (H1N1) pneumonia
severity or subsequent requirement for ICU admission and the
most sensitive rapid diagnostic tool for pandemic influenza (H1N1)
2009 pneumonia was rRT-PCR testing on lower respiratory tract
samples, as nasopharyngeal samples were often negative. Pro-
longed rRT-PCR positivity in lower respiratory tract samples was
the norm, despite universal use of oseltamivir during admission.
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